OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
OCAT was delisted on the 9th of February, 2016.
31 hedge funds and large institutions have $2.17M invested in OCATA THERAPEUTICS, INC. COMMON STOCK in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $80K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$391K |
| 2 |
Morgan Stanley
New York
|
+$360K |
| 3 |
Millennium Management
New York
|
+$332K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$177K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$163K |
Top Sellers
OCAT Hedge Fund Activity: Q1 2015 in Review
31 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) for Q1 2015, worth a combined $2.17M.
Buyers outnumbered sellers: 31 funds opened new OCAT positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $391K.
- 31 institutional investors held OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) as of Q1 2015, up from 0 in Q4 2014.
- Funds reported $2.17M of OCATA THERAPEUTICS, INC. COMMON STOCK stock for Q1 2015.
- 31 funds opened new OCATA THERAPEUTICS, INC. COMMON STOCK positions in Q1 2015 and 0 closed out, a net change of +31 holders.
- The largest OCATA THERAPEUTICS, INC. COMMON STOCK buyer in Q1 2015 was Susquehanna International Group, an estimated $391K added.
Based on aggregated 13F filings for Q1 2015.